Mastodon

Asinis® (Drops) Instructions for Use

Marketing Authorization Holder

Richard Bittner, AG (Austria)

ATC Code

R05X (Other remedies for the treatment of colds)

Dosage Form

Bottle OTC Icon Asinis® Homeopathic drops: dropper bottle 20 ml, 50 ml, or 100 ml

Dosage Form, Packaging, and Composition

Homeopathic drops in the form of a clear liquid with a yellowish tint and a specific odor.

100 ml
Horseradish (Armoracia) D1 10 ml
Goldenseal (Hydrastis) D6 10 ml
Red Mercuric Sulfide (Cinnabaris) D12 10 ml
Calcium Sulfate (Calcium sulfate) D12 10 ml
Potassium Dichromate (Potassium dichromate) D6 10 ml

Excipients : ethanol 43% by weight.

20 ml – dark glass bottles with a dropper (1) – cardboard boxes.
50 ml – dark glass bottles with a dropper (1) – cardboard boxes.
100 ml – dark glass bottles with a dropper (1) – cardboard boxes.

Clinical-Pharmacological Group

Homeopathic preparation used for sinusitis

Pharmacotherapeutic Group

Homeopathic agent

Pharmacological Action

A complex homeopathic preparation, the action of which is due to the properties of the components included in its composition.

It has anti-inflammatory, antimicrobial, immunostimulating, and detoxifying effects, reduces increased secretion in the nasal sinuses, and facilitates nasal breathing.

Pharmacokinetics

The action of Asinis® is the result of the combined action of its components; therefore, conducting kinetic observations is not possible. The components collectively cannot be tracked using markers or bioassays. For the same reason, it is also impossible to detect the drug’s metabolites.

Indications

As part of complex therapy for diseases of the nasal cavity and paranasal sinuses, including:

  • Sinusitis;
  • Frontitis;
  • Chronic rhinitis.

ICD codes

ICD-10 code Indication
J01 Acute sinusitis
J31 Chronic rhinitis, nasopharyngitis and pharyngitis
J32 Chronic sinusitis
ICD-11 code Indication
CA01 Acute rhinosinusitis
CA09 Chronic rhinitis, nasopharyngitis or pharyngitis
CA0A.Z Chronic rhinosinusitis, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

For adults and adolescents over 12 years, the drug is prescribed 10 drops 3 times/day. The course of treatment is 2-4 weeks. If necessary, the course of treatment can be repeated after 1 month following consultation with a doctor.

In cases requiring rapid relief of symptoms, it is possible to take it every 0.5-1 hour until improvement occurs (but not more than 8 times), after which it should be taken 3 times/day.

It is taken orally undiluted or after dilution in 1 tablespoon of water, 30 minutes before or 1 hour after a meal, holding it in the mouth for 20-30 seconds before swallowing.

Adverse Reactions

Rarely: increased salivation.

The patient should be informed that if other side effects occur, they should consult a doctor.

Contraindications

  • Hypersensitivity to the components of the drug.

Use in Pregnancy and Lactation

The decision on the use of Asinis® during pregnancy and lactation (breastfeeding) is made by the doctor individually.

Pediatric Use

There are no data on the use of the drug in children under 12 years of age.

Special Precautions

Since Asinis® contains natural herbal components, slight cloudiness of the solution or weakening of the odor and taste may be observed during storage, which does not lead to a decrease in the drug’s effectiveness.

Overdose

Cases of overdose have not been reported to date.

Drug Interactions

Clinically significant interaction of Asinis® with other medicinal products has not been established.

Storage Conditions

The drug should be stored at a temperature not exceeding 25°C (77°F) in a place protected from light and strong electromagnetic fields, out of the reach of children.

Shelf Life

The shelf life is 5 years. Do not use after the expiration date printed on the packaging.

Dispensing Status

The drug is approved for use as an over-the-counter product.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS